Opportunistic infections in patients with Hiv and Aids fungal and parasitic infections

Since the advent of highly active antiretroviral therapy [HAART], the incidence of specific fungal and parasitic opportunistic infections as observed in HIV disease has been in decline. However, in many parts of the world, and in areas where access to HAART is limited, these specific opportunistic infections are still observed in HIV patients. In this manuscript, we review the epidemiology, clinical manifestations, diagnosis, and treatment of common fungal and parasitic opportunistic infections